Hypercalcemia, hypercalciuria, and kidney stones in long-term studies of vitamin D supplementation: a systematic review and meta-analysis
Malihi Z, Wu Z, Stewart AW, Lawes CM, Scragg R
The American journal of clinical nutrition · 103 citas
Cómo se estudió
- Diseño
- Metaanálisis (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Eventos clínicos como enfermedad o muerte
Quién lo pagó
- Financiación
- Financiación independiente
- Universidad u hospital
- University of Auckland
- Gobierno
- China Scholarship Council
Según 2 financiadores declarados.
Publicación
- Publicado
- 2016-09-07 · Am J Clin Nutr · vol. 104 · número 4 · págs. 1039–1051
- Editorial
- Elsevier BV
- Citado
- 153 citas · más que el 90% de estudios similares · 2.6× el promedio de su campo
- Referencias
- 86 trabajos
- Acceso
- Lectura gratuita
- Áreas de investigación
- Vitamin D Research Studies · Parathyroid Disorders and Treatments · Kidney Stones and Urolithiasis Treatments
- Palabras clave
- vitamin D supplementation, hypercalcemia, hypercalciuria, kidney stones, calcium metabolism, adverse effects, long-term supplementation, 25-hydroxyvitamin D, dose-response relationship
- MeSH
- humans, kidney calculi, hypercalcemia, calcium, vitamins, vitamin d, dietary supplements, adult, aged, aged, 80 and over, middle aged, female, male, hypercalciuria, young adult
5 autores
- Zarintaj A. Malihi🇳🇿University of Auckland
- Zhenqiang Wu🇳🇿University of Auckland
- Alistair W. Stewart🇳🇿University of Auckland
- Carlene M.M. Lawes🇳🇿University of Auckland
- Robert K.R. Scragg🇳🇿 · autor de correspondenciaUniversity of Auckland
Resumen
El texto original del estudio, en el idioma en que se publicó.
Background
Vitamin D supplementation is increasingly being used in higher doses in randomized controlled trials (RCTs). However, adverse events from very large annual doses of vitamin D have been shown in 2 RCTs, whereas in a third RCT, low-dose vitamin D, with calcium supplements, was shown to increase kidney stone risk.
Objective
We analyzed the side effects related to calcium metabolism in RCTs, specifically hypercalcemia, hypercalciuria, and kidney stones, in participants who were given vitamin D supplements for ≥24 wk compared with in subjects in the placebo arm.
Design
The following 3 main online databases were searched: Ovid Medline (PubMed), EMBASE, and the Cochrane Library. Software was used for the meta-analysis.
Results
A total of 48 studies with 19,833 participants were identified, which reported ≥1 of the following side effects: hypercalcemia, hypercalciuria, or kidney stones. Of these studies, kidney stones were reported in only 9 trials with a tendency for fewer subjects reporting stones in the vitamin D arm than in the placebo arm (RR: 0.66, 95% CI: 0.41, 1.09; P = 0.10). In 37 studies, hypercalcemia was shown with increased risk shown for the vitamin D group (RR: 1.54; 95% CI: 1.09, 2.18; P = 0.01). Similar increased risk of hypercalciuria was shown in 14 studies for the vitamin D group (RR: 1.64; 95% CI: 1.06, 2.53; P = 0.03). In subgroup analyses, it was shown that the effect of vitamin D supplementation on risk of hypercalcemia, hypercalciuria, or kidney stones was not modified by baseline 25-hydroxyvitamin D, vitamin D dose and duration, or calcium co-supplementation.
Conclusions
Long-term vitamin D supplementation resulted in increased risks of hypercalcemia and hypercalciuria, which were not dose related. However, vitamin D supplementation did not increase risk of kidney stones. Additional large RCTs of long-term vitamin D supplementation are required to confirm these findings.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.